Design and synthesis of a novel class of histone deacetylase inhibitors-Reference-Cited by-同舟云学术

Design and synthesis of a novel class of histone deacetylase inhibitors

Published:2001-11 Issue:21 Volume:11 Page:2847-2850
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Lavoie Rico,Bouchain Giliane,Frechette Sylvie,Woo Soon Hyung,Khalil Elie Abou,Leit Silvana,Fournel Marielle,Yan Pu T.,Trachy-Bourget Marie-Claude,Beaulieu Carole,Li Zuomei,Besterman Jeffrey,Delorme Daniel

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs

2. Histone acetylases and deacetylases in cell proliferation

3. The language of covalent histone modifications

4. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription

5. Role of the histone deacetylase complex in acute promyelocytic leukaemia

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Density functional theory (DFT) studies in HDAC-based chemotherapeutics: Current findings, case studies and future perspectives;Computers in Biology and Medicine;2024-06

2. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors;Molecular Diversity;2022-10-10

3. Exploration of 4-(1H-indol-3-yl)cyclohex-3-en-1-amine analogues as HDAC inhibitors: Design, synthesis, biological evaluation and modelling studies;Bioorganic & Medicinal Chemistry Letters;2022-09

4. Design, Synthesis, and in vitro Evaluation of Tubulin‐Targeting Dibenzothiazines with Antiproliferative Activity as a Novel Heterocycle Building Block;ChemMedChem;2021-07-29

5. Molecular dynamics-guided receptor-dependent 4D-QSAR studies of HDACs inhibitors;Molecular Diversity;2021-02-24